Results 1 to 10 of about 9,315,415 (239)

Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity. [PDF]

Drug Dev Res
Koçak Aslan E, Lam K, Huang S, Coşkun GP, Karagüzel A, Denzinger K, Birgül K, Ülgen M, Nafie JW, Şahin O, Armstrong DW, Zamponi GW, Wolber G, Gündüz MG.   +13 more
europepmc   +1 more source

Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions. [PDF]

Diseases
Katsi V, Papadomarkaki K, Manousiadis K, Triantafyllou E, Fragoulis C, Tsioufis K.   +5 more
europepmc   +1 more source

The single Fe atoms and DDQ catalyst system for the aerobic dehydrogenation of dihydropyridines and dihydroquinazolinones. [PDF]

Sci Rep
Veisi H, Rostami A.
europepmc   +1 more source

Benzimidazole derivatives as dual EGFR and BRAF^V600E inhibitors with pro-apoptotic antiproliferative potential. [PDF]

RSC Adv
Al-Wahaibi LH, Samir M, Bräse S, Youssif BGM, Morcoss MM.   +4 more
europepmc   +1 more source

Characterizing the 1,4-dihydropyridines binding interactions in the L-Type CA²+ channel: model construction and docking calculatins

, 2007
Cosconati, Sandro
core  

Cardiac Myosin Inhibitors (CMIs) and Surgical Referral in Patients with Hypertrophic Cardiomyopathy. [PDF]

J Cardiovasc Dev Dis
Ferraresi B, Nenna A, Jawabra M, Corrado D, Faggiano A, Carugo S, Dominici C, Casali G, Chello M, Lusini M.   +9 more
europepmc   +1 more source

Life-Threatening Amlodipine Overdose: A Rare Case of Noncardiogenic Pulmonary Edema and Respiratory Failure Requiring ICU Care. [PDF]

Clin Case Rep
Pandit R, Masuta P, Regmi N, Nepali A, Acharya G, Jibran M, Maharjan H, Shrestha N.   +7 more
europepmc   +1 more source

Comparison between 1,2-Dihydropyridine and 1,4-Dihydropyridine on Hydride-Donating Ability and Activity

Molecules, 2022
Jin-Ye Zhang, Xiao-Qing Zhu
exaly